Deutsche Bank analyst George Hill upgraded CVS Health (CVS) to Buy from Hold with an unchanged price target of $66. The firm believes both the company’s earnings and multiple are now likely near trough levels. CVS has taken steps to turn the company towards improving profitability, the analyst tells investors in a research note. Following an analysis of the managed care segment, Deutsche thinks an earnings recovery is both achievable and will outpace Street expectations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health upgraded to Buy from Hold at Deutsche Bank
- RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule
- CVS Health price target raised to $80 from $73 at TD Cowen
- CVS Health price target lowered to $64 from $72 at Piper Sandler
- Trump Weekly: Trump looks to drop EV tax credit, fuel-efficiency requirements